Matricaria Recutita Extract (Chamomile) to reduce Candida Albicans and Entrobacter Cloacae biofilms: in vitro study
Authors:
- Maitê Alves PequenoMPMaitê Alves Pequeno
- Marissa Rodrigues SilvestreMSMarissa Rodrigues Silvestre
- Isabela AmêndolaIAIsabela Amêndola
- Célia Regina Gonçalves e SilvaCSCélia Regina Gonçalves e Silva
- Mariella Vieira Pereira LeãoMLMariella Vieira Pereira Leão
- Silvana Soleo Ferreira dos SantosSSSilvana Soleo Ferreira dos Santos
Open Access
- 1 June 2018
- journal article
- research article
- Published by FapUNIFESP (SciELO) in RGO - Revista Gaúcha de Odontologia
- Vol. 66 (2) , 122-128
Abstract
Objective: This research study aimed at evaluating the inhibitory activity of Matricaria recutira (chamomile) hydroalcoholic extract on Candida albicans and Enterobacter cloacae biofilms. Methods: C. albicans and E. cloacae biofilms with thirty-hour formation were submitted, for five minutes, to 100, 200 and 300 mg / mL of M. recutita hydroalcoholic extract, chlorhexidine digluconate 0.12% (Periogard® - inhibition control) or sterile distilled water (growth control). Subsequently, they were washed and divided into two groups to determine the microbial viability: G/UFC - counting of colony forming units (cfu) in agar and G/DNA - quantification of viable DNA with violet crystal dye by spectrophotometry. Results: M. recutita extract at 300 mg/mL reduced significantly (p <0.01) the E. cloacae cfu/mL number in biofilm with results similar to chlorhexidine 0.12%, while extracts at 100 and 200 mg/mL did not have the same effectiveness. The amount of E. cloacae viable DNA was reduced (p <0.05) in all the M. recutita extract concentrations and chlorhexidine. There was no significant difference (p = 0.565) in the cfu/mL number or in the amount of viable DNA (p = 0.8094) in C. albicans biofilm when compared to untreated biofilm (control) or, even, between the extracts when compared to each other or to chlorhexidine 0.12%. Conclusion: 300 mg/mL M. recutita extract reduced significantly the E. cloacae biofilm but not the C. albicans, both with a similar result to chlorhexidine 0.12% (Periogar®).Keywords
This publication has 20 references indexed in Scilit:
- Lactobacillus is able to alter the virulence and the sensitivity profile of Candida albicansJournal of Applied Microbiology, 2016
- The Oral Microbiota2016
- Candida albicans biofilms: development, regulation, and molecular mechanismsMicrobes and Infection, 2016
- Plants and other natural products used in the management of oral infections and improvement of oral healthActa Tropica, 2016
- Candida albicans Biofilms and Human DiseaseAnnual Review of Microbiology, 2015
- IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansThe Journal of Immunology, 2015
- Clinical efficacy analysis of the mouth rinsing with pomegranate and chamomile plant extracts in the gingival bleeding reductionComplementary Therapies in Clinical Practice, 2014
- Avaliação Comparativa “In Vivo” da Eficácia do Óleo de Melaleuca, Clorexidina e Listerine sobre Streptococcus mutans e Microrganismos Totais na SalivaPesquisa Brasileira em Odontopediatria e Clínica Integrada, 2013
- Enterobacter cloacae Complex: Clinical Impact and Emerging Antibiotic ResistanceFuture Microbiology, 2012
- Enterobacteriaceae and pseudomonadaceae on the dorsum of the human tongueJournal of Applied Oral Science, 2009